ISPC iSpecimen Corp: Company Value to Revenue Ratio

iSpecimen Inc (ISPC) - corporate logo

iSpecimen Inc. (ISPC) is implementing eco-friendly digital document management while ensuring strict data cybersecurity. The EV/Sales ratio reflects the dynamics of this process, with the parameter reaching -3783.33. The company's revenues are based on the R&D expenditures of pharmaceutical laboratories and a network of donor centers. System stability is maintained through targeted managerial hiring and the retention of key IT architects for the marketplace.

iSpecimen Inc - ISPC EV/Sales Multiple (period 11/23/2025 - 11/20/2026)

iSpecimen - analytical breakdowns and key metrics (ISPC)

- price and consensus price forecast:
Fundamental valuation:ISPC (iSpecimen Inc)
Finished products of ispecimen.com

This indicator compares the total enterprise value, including debt, with sales volume, allowing for the determination of the actual premium paid per unit of revenue without distortions from the financial structure. By analyzing the EV-to-revenue ratio, an investor can see how geopolitical barriers in the exchange of biomaterials are constraining the revenue growth of iSpecimen Inc. (ISPC), which directly impacts the fundamental stability of the company's valuation.

Competitor analysis for iSpecimen Inc.

Enterprise Value-to-Revenue Multiple veeva.com|DOCS (Doximity) - Company Value to Revenue|HQY - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Waystar Inc.|CRVL: Business Value to Revenue|Enterprise Value-to-Revenue Ratio Privia Health Group (PRVA)|EV/Sales Multiple huronconsultinggroup.com (HURN)|Certara Inc - Company Value to Revenue|OMCL - Company Value to Revenue|GDRX - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Schrodinger Corp SDGR|PHR: EV/Sales Multiple|OMDA - Total Company Value-to-Revenue Ratio|EVH (Evolent Health Inc) - EV/Sales Multiple|Company Value to Revenue Ratio HSTM (HealthStream)|EV/Sales Multiple DH|CCSI (Consensus Corp) - Business Value to Revenue|agilon health Inc - Company Value to Revenue|absci.com - Enterprise Value-to-Revenue Ratio|SY - Enterprise Value-to-Revenue Ratio|Business Value to Revenue NRC (National Research)|USA Mobility (SPOK) - Enterprise Value-to-Revenue Ratio|OPRX: Enterprise Value-to-Revenue Coefficient|Company Value to Revenue TBRG|simulations-plus.com (SLP) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio sophiagenetics.com (SOPH)|HCAT (Health Catalyst) - Business Value to Revenue|Enterprise Value-to-Revenue Ratio CareCloud, Inc. CCLD|Total Company Value-to-Revenue Ratio Research Solutions (RSSS)|DLH Corp - EV/Sales Multiple|ONMD (OneMedNet) - Company Value to Revenue Ratio|SCNX: EV/Sales Multiple|HCTI - Total Company Value-to-Revenue Ratio|BFRG (Bullfrog AI) - EV/Sales Multiple|Company Value to Revenue SCWorx Inc (WORX)|EV/Sales Multiple MSPR|ICCT - Enterprise Value-to-Revenue Multiple|EV/Sales Multiple MEDS (TRxADE Health Corp)|Enterprise Value-to-Sales Ratio Orgenesis|R1 RCM - EV/Sales Multiple|Business Value to Revenue SHCR (Sharecare, Inc)|STRM (Streamline Health Solutions Inc.) - Company Value to Revenue|Enterprise Value-to-Revenue Multiple syrahealth.com (SYRA)|Company Value to Revenue AMEH|MODN: Business Value to Revenue|Company Value to Revenue NXGN (NextGen Healthcare)